Q & A

Read the latest PLC CEO interviews. CEO’s from UK listed PLC’s, Analysts and Fund Managers answering questions about their business.

N4 Pharma Q&A: Confirming Nuvec’s versatility (LON:N4P)

N4 Pharma plc (LON:N4P) Chief Executive Officer Nigel Theobald caught up with DirectorsTalk for an exclusive interview to discuss their latest operational update, the importance of demonstrating formulation, key milestones..

November 12, 2020

Tern Q&A: Talking Medicines investment providing synergies across the portfolio (LON:TERN)

Tern plc (LON:TERN) Chief Executive Officer Albert Sisto caught up with DirectorsTalk for an exclusive interview to discuss their recent investment in Talking Medicines, how to funds will be used,..

November 11, 2020

Pantheon International Analyst Q&A: NAV resilience through downturns (LON:PIN)

Pantheon International plc (LON:PIN) is the topic of conversation when Hardman and Co’s Analyst Mark Thomas caught up with DirectorsTalk for an exclusive interview. Q1: You called your piece on..

November 11, 2020

CentralNic Group Q&A: Codewise acquisition “a really fantastic deal” (LON:CNIC)

CentralNic Group plc (LON:CNIC) Chief Executive Officer Ben Crawford caught up with DirectorsTalk for an exclusive interview to discuss the Codewise acquisition, potential synergies and KeyDrive meeting expectations. Q1: Ben,..

November 6, 2020

Touchstone Exploration Q&A “very, very busy news flow over the next 90 days” (LON:TXP)

Touchstone Exploration Inc (LON:TXP) Chief Executive Officer Paul Baay caught up with DirectorsTalk for an exclusive interview to discuss their latest operational update, being ahead of schedule, the nine-month licence..

November 6, 2020

Biome Technologies Q&A: 48% revenue growth in bioplastics division (LON:BIOM)

Biome Technologies plc (LON:BIOM) Chief Executive Officer Paul Mines caught up with DirectorsTalk for an exclusive interview to discuss the 48% revenue increase in the bioplastics division, what will drive..

November 3, 2020

Falanx Cyber Defence Q&A “acceleration of the pent up demand” (LON:FLX)

Falanx Cyber Defence Ltd, part of the Falanx Group Ltd (LON:FLX) Managing Director Rick Flood caught up with DirectorsTalk for an exclusive interview to discuss joining the SolarWinds Technology Alliance..

October 30, 2020

Ferro-Alloy Resources Q&A: Significant news flow to come (LON:FAR)

Ferro-Alloy Resources Ltd (LON:FAR) Chief Executive officer Nick Bridgen caught up with DirectorsTalk for an exclusive interview to discuss why they are producing molybdenum, the financial significance and what investors..

October 30, 2020

Escape Hunt Analyst Q&A “acquisition offers very high potential return” (LON:ESC)

Escape Hunt plc (LON:ESC) is the topic of conversation when Zeus Capital’s Technology Analyst Bob Liao caught up with DirectorsTalk for an exclusive interview. Q1: ESC announced the acquisition of..

October 29, 2020

Tissue Regenix Analyst Q&A: Very well positioned to reach breakeven and become cash generative (LON:TRX)

Tissue Regenix plc (LON:TRX) is the topic of conversation when Hardman and Co’s Analyst Dr Martin Hall caught up with DirectorsTalk for an exclusive interview. Q1: This is the first..

October 29, 2020

Tatton Asset Management Analyst Q&A: AuM 4% above Zeus Capital expectations (LON:TAM)

Tatton Asset Management plc (LON:TAM) is the topic of conversation when Zeus Capital’s Research Analyst Robin Savage caught up with DirectorsTalk for an exclusive interview. Q1: Tatton Asset Management has..

October 27, 2020

Guild Esports Analyst Q&A: A very strong start with ambitious plans (LON:GILD)

Guild Esports plc (LON:GILD) is the topic of conversation when Zeus Capital’s Technology Analyst Bob Liao caught up with DirectorsTalk for an exclusive interview. Q1: Guild Esports, the esports team..

October 27, 2020

Blackrock Latin American Investment Trust Analyst Q&A with Edison Investment Research (LON:BRLA)

BlackRock Latin American Investment Trust plc (LON:BRLA) is the topic of conversation when Edison Investment Research’s Managing Director Rob Murphy caught up with DirectorsTalk for an exclusive interview. Q1: I..

October 22, 2020

SpaceandPeople Analyst Q&A: Recovery is in hand (LON:SAL)

SpaceandPeople plc (LON:SAL) is the topic of conversation when Zeus Capital’s Research Analyst Robin Byde caught up with DirectorsTalk for an exclusive interview. Q1: I wanted you to talk to..

October 22, 2020

Advanced Oncotherapy Analyst Q&A: Positioned well for CE certification application (LON:AVO)

Advanced Oncotherapy plc (LON:AVO) is the topic of conversation when Hardman and Co’s Analyst Dr Martin Hall caught up with DirectorsTalk for an exclusive interview. Q1: You recently released a..

October 22, 2020

AB Dynamics Analyst Q&A “£30 million in net cash on the balance sheet” (LON:ABDP)

AB Dynamics plc (LON:ABDP) is the topic of conversation when Zeus Capital’s Research Analyst Robin Byde caught up with DirectorsTalk for an exclusive interview. Q1: AB Dynamics, you’ve recently initiated..

October 20, 2020

OnTheMarket Analyst Q&A “enterprise value to continue to increase” (LON:OTMP)

OnTheMarket plc (LON:OTMP) is the topic of conversation when Zeus Capital’s Research Analyst Robin Savage caught up with DirectorsTalk for an exclusive interview. Q1: OnTheMarket, the majority owned company which..

October 20, 2020

Applied Graphene Materials Q&A “looking forward to further successful product launches” (LON:AGM)

Applied Graphene Materials plc (LON:AGM) Chief Executive officer Adrian Potts caught up with DirectorsTalk for an exclusive interview to discuss full year results, their new commercial service offering ‘Innovation Accelerator’..

October 20, 2020

Serinus Energy Q&A: Accelerating the economic returns (LON:SENX)

Serinus Energy plc (LON:SENX) Chief Executive Officer Jeffrey Auld caught up with DirectorsTalk for an exclusive interview to discuss receiving approval for the licence extension and amended work commitment, how..

October 20, 2020

Arix Bioscience Analyst Q&A: Investment team very focused and motivated (LON:ARIX)

Arix Bioscience plc (LON:ARIX)is the topic of conversation when Hardman and Co’s Analyst Martin Hall caught up with DirectorsTalk for an exclusive interview. Q1: Can you tell us what Arix..